Quick Answer
BIODESIX INC reported Total Assets of $87.48 million for the year ending 2025.
- BIODESIX INC showed a decrease of -10.0% in Total Assets from 2024 to 2025.
- This data is from BIODESIX INC's annual report (Form 10-K), filed with the SEC on February 26, 2026.
- XBRL data for this metric is available from 2019 to 2025 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2020: $46.55 million | Q1 2021: $115.49 million | Q2 2021: $101.80 million | Q3 2021: $90.00 million | Q1 2022: $61.65 million | Q2 2022: $75.23 million | Q3 2022: $63.20 million | Q1 2023: $80.79 million | Q2 2023: $77.62 million | Q3 2023: $86.79 million | Q1 2024: $87.20 million | Q2 2024: $115.84 million | Q3 2024: $102.74 million | Q1 2025: $86.24 million | Q2 2025: $87.74 million | Q3 2025: $88.72 million.
- Over the full 7 years of available data (2019 to 2025), BIODESIX INC's Total Assets has grown by 94.2%.
- Historical annual values: Fiscal year 2025: $87.48 million | Fiscal year 2024: $97.24 million | Fiscal year 2023: $99.10 million | Fiscal year 2022: $92.91 million | Fiscal year 2021: $76.10 million | Fiscal year 2020: $121.07 million | Fiscal year 2019: $45.03 million.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: